Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

The new follicular unit extraction treatment effectively treats severe hair loss in Asian men, giving natural-looking results with few side effects.

Childhood cancer survivors need better skin care and sun protection.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Identified genes linked to male-pattern baldness may help develop new treatments.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.